Dertinger Stephen D, Camphausen Kevin, Macgregor James T, Bishop Michelle E, Torous Dorothea K, Avlasevich Svetlana, Cairns Siân, Tometsko Carol R, Menard Cynthia, Muanza Thierry, Chen Yuhchyau, Miller Richard K, Cederbrant Karin, Sandelin Kerstin, Pontén Ingrid, Bolcsfoldi George
Litron Laboratories, Rochester, New York 14620, USA.
Environ Mol Mutagen. 2004;44(5):427-35. doi: 10.1002/em.20075.
Experiments described herein were designed to evaluate the performance characteristics of a flow cytometry-based system that scores the incidence of peripheral blood micronucleated reticulocytes (MN-RETs). These procedures represent the continued refinement of a previously reported anti-CD71-based method (Dertinger et al. [1996]: Mutat Res 371:283-292), with the following modifications: incorporation of a third fluorescent label to exclude platelets from the MN-RET region, and use of a CD71-associated fluorescence thresholding technique to increase data acquisition rates. Mouse, rat, and human blood samples were analyzed using both the previously described two-color procedure (anti-CD71-FITC and propidium iodide) and a newly developed three-color technique (which adds an antiplatelet-PE antibody). The rodent specimens were also evaluated by standard microscopy procedures (acridine orange staining). Mouse blood was collected via heart puncture of vehicle- and 5-fluorouracil-treated CD-1 mice; blood samples from saline-treated Sprague-Dawley rats were collected from the tail vein and via heart puncture. Rodent blood samples were analyzed by both the two- and three-color methods. Human blood specimens, obtained via arm venipuncture from cancer patients undergoing radiation therapy, were analyzed for MN-RETs using the two-color method. Subsequently, blood samples from a single chemotherapy patient were analyzed by both the two- and three-color methods. Finally, the chemotherapy patient blood samples and blood samples from 15 healthy volunteers were evaluated at very high densities in conjunction with a CD71-associated fluorescence thresholding technique. Results of these investigations showed that data from mouse blood analyzed by the two- and three-color procedures correlated well with microscopy data (r values = 0.917 and 0.937 for the two- and three-color methods, respectively); all three methods confirmed the genotoxicity of 5-FU. Data from rat tail vein samples showed improved reproducibility with the three-color technique, but no significant difference between the two techniques was seen with the heart puncture specimens. Human blood analyzed according to the two-color procedure produced unreliable results, as platelets and platelet aggregates impacted the rare MN-RET scoring region. The three-color technique effectively overcame this problem and produced reproducible measurements that fell within expected ranges. For human blood analyses, the high cell density/CD71-thresholding technique provided significant improvements over the low-density technique, as it allowed data acquisition to occur approximately six times faster with no loss of sensitivity.
本文所述实验旨在评估一种基于流式细胞术的系统的性能特征,该系统用于对外周血微核网织红细胞(MN-RET)的发生率进行评分。这些程序是对先前报道的基于抗CD71的方法(Dertinger等人[1996]:《突变研究》371:283 - 292)的持续改进,有以下修改:加入第三种荧光标记以将血小板排除在MN-RET区域之外,并使用与CD71相关的荧光阈值技术来提高数据采集率。使用先前描述的双色程序(抗CD71 - FITC和碘化丙啶)以及新开发的三色技术(添加抗血小板 - PE抗体)对小鼠、大鼠和人类血液样本进行分析。啮齿动物标本也通过标准显微镜程序(吖啶橙染色)进行评估。通过心脏穿刺采集载体处理和5 - 氟尿嘧啶处理的CD - 1小鼠的血液;从经盐水处理的Sprague - Dawley大鼠的尾静脉和通过心脏穿刺采集血液样本。通过双色和三色方法对啮齿动物血液样本进行分析。通过手臂静脉穿刺从接受放射治疗的癌症患者获取人类血液标本,使用双色方法分析MN-RET。随后,通过双色和三色方法对一名化疗患者的血液样本进行分析。最后,结合与CD71相关的荧光阈值技术以非常高的密度评估化疗患者的血液样本和15名健康志愿者的血液样本。这些研究结果表明,通过双色和三色程序分析的小鼠血液数据与显微镜数据相关性良好(双色和三色方法的r值分别为0.917和0.937);所有三种方法均证实了5 - FU的遗传毒性。大鼠尾静脉样本的数据显示三色技术的重现性有所提高,但心脏穿刺标本在两种技术之间未观察到显著差异。按照双色程序分析的人类血液产生了不可靠的结果,因为血小板和血小板聚集体影响了罕见的MN-RET评分区域。三色技术有效地克服了这个问题,并产生了在预期范围内的可重现测量结果。对于人类血液分析,高细胞密度/CD71阈值技术比低密度技术有显著改进,因为它使数据采集速度提高了约六倍且不损失灵敏度。